Log in
Enquire now
Aboleris Pharma

Aboleris Pharma

AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.

OverviewStructured DataIssuesContributors

Contents

aboleris-pharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Immunotherapy
Immunotherapy
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Pharmaceutical industry
Pharmaceutical industry
Location
Belgium
Belgium
Nantes
Nantes
France
France
B2X
B2B
B2B
CEO
Pitchbook URL
pitchbook.com/profiles...453420-28
Number of Employees (Ranges)
1 – 10
Email Address
Investors
Sound Bioventures
Sound Bioventures
Caixa Capital Risc
Caixa Capital Risc
Turenne Groupe
Turenne Groupe
0
Founded Date
January 1, 2019
Total Funding Amount (USD)
61,000,000
Latest Funding Round Date
September 19, 2023
Latest Funding Type
Series A
Series A
Country
France
France
Headquarters
Nantes
Nantes

Other attributes

Latest Funding Round Amount (USD)
29,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Aboleris Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.